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A Gelatin-sulfonated Silk 
Composite Scaffold based on 3D 
Printing Technology Enhances 
Skin Regeneration by Stimulating 
Epidermal Growth and Dermal 
Neovascularization
Si Xiong1,2,6, Xianzhu Zhang1,2,6, Ping Lu1,2,6, Yan Wu1,2,6, Quan Wang  1,2,6, Heng Sun1,2,6, 
Boon Chin Heng3, Varitsara Bunpetch1,2,6, Shufang Zhang1,2,6 & Hongwei Ouyang1,2,4,5,6
One of the key problems hindering skin repair is the deficiency of dermal vascularization and difficulty 
of epidermis regeneration, which makes it challenging to fabricate scaffolds that can biologically fulfill 
the requirements for skin regeneration. To overcome this problem, three-dimensional printing was used 
to fabricate a gelatin-sulfonated silk composite scaffold that was incorporated with basic fibroblast 
growth factor 2 (FGF-2) through binding with a sulfonic acid group (SO3) (3DG-SF-SO3-FGF). The efficacy 
and mechanism by which the 3DG-SF-SO3-FGF scaffolds promote skin regeneration were investigated 
both within in vitro cell culture and in vivo with a full-thickness skin defect model. The histological 
results showed that the gelatin-sulfonated silk composite scaffolds promoted granulation, and that 
incorporation of FGF-2 significantly enhanced the regeneration of skin-like tissues after implantation in 
rat skin defects for 14 and 28 days. Further investigations demonstrated that 3DG-SF-SO3-FGF scaffolds 
might stimulate dermal vascularization. These findings thus suggest that incorporation of FGF-2 into 
the 3D printed scaffolds is a viable strategy for enhancing skin regeneration.
Skin is the largest organ in our body and primarily serves as a protective barrier between the body and the exter-
nal environment. Skin injury is commonly encountered in the clinic due to unavoidable direct exposure of skin 
to potentially harmful microbial, mechanical, thermal and chemical insults in daily life, as well as internal factors 
arising from various medical conditions such as diabetes, obesity and aging1. Although most cutaneous defects 
can heal naturally, some acute and chronic skin loss conditions such as venous ulcer and diabetes require hospi-
talization, resulting in reduced quality of life, as well as substantial socio-economic burden2. Approximately 67 
million people (1% to 5% of the world’s population) worldwide suffer from chronic skin wounds, with 6.5 million 
people in the United States alone, resulting in healthcare costs exceeding $25 billion3.
The development of skin tissue engineering, which aims to achieve full recovery of skin biological functions, 
can address pertinent clinical challenges of donor site morbidity and immune-rejection faced in utilizing auto-
grafts and allografts in conventional treatment of skin injuries2, respectively. Extraordinary advances in skin 
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regeneration have been achieved recently due to rapid progress in the various elements of tissue engineering 
(seeding cells, scaffolds and growth factors) and their combined synergistic contributions to the field of skin 
tissue engineering. Nevertheless, the treatment of full thickness skin defects still remains a formidable clinical 
challenge. Scaffolds seeded with autologous cells, particularly adult stem cells, offer much promise for treatment 
of skin injuries. However, utilizing autologous cells in skin regeneration is expensive and time-consuming, which 
would necessitate the development of new strategies4. A plausible alternative strategy to utilize autologous cells 
could be the mobilization and homing of endogenous cells in wound healing through the use of cell-free materials 
incorporated with biologically active molecules5–7.
Three-dimensional (3D) printing is a flexible automated on-demand platform for the free-form fabrication of 
complex and intricate architectures, enabling the creation of novel bio-scaffolds and viable tissues and organs for 
regenerative medicine8. Different types of biomaterials have been employed to fabricate skin substitutes includ-
ing naturally derived polymers (alginate, gelatin, collagen, chitosan, fibrin and hyaluronic acid), synthetic mol-
ecules (polyethylene glycol, PEG) and their cross-linking agents9, 10. Amongst these materials, gelatin, a form of 
hydrolyzed collagen, has attracted much attention due to its similarity to human extracellular matrix (ECM) and 
its amenability for suspending cells within a gel environment at low temperature11. However, the mechanical 
weakness and rapid degradation property behavior of gelatin hydrogels are two major disadvantages that severely 
limit their clinical applications. Therefore, various chemical modifications have been carried out to improve the 
physical and biological properties of gelatin hydrogels12, 13.
Silk fibroin (SF) is a natural polymer produced by a variety of insects and spiders. It has been increasingly 
investigated and employed as scaffolds to modulate cell behavior. Due to its good biocompatibility, impressive 
mechanical properties, environmental stability, and non-inflammatory response, SF scaffolds could be utilized as 
an effective tool in repairing skin, bone, cartilage, ligament and tendon, vascular, neural, tracheal and bladder tis-
sues14–20. In the field of drug delivery, SF has also been applied and demonstrated its controlled release kenetics21–25. 
Nevertheless, the slow degradation rate of SF poses a major concern26, 27. Recently, there are increasing evidence 
to suggest that SF degradation can be accelerated by diminishing the formation of beta-amyloid structures or 
through incorporation of other rapid-degrading materials28, 29. Hence, gelatin was incorporated during the initial 
process of scaffold fabrication. Furthermore, we utilized the 3D printed gelatin grid to provide a base for final 
molding of the silk fibroin solution, as well as to provide larger pores for speeding up the degradation process.
In this study, we fabricated the 3D-printed scaffold in the form of a “porous grid scaffold”, in which the 
3D-printed gelatin grid functioned as the basic structural network that was coated with the sulfonated silk fibroin 
derivative. This composite scaffold can serve as a “porous magnet” to sequester and concentrate basic fibroblast 
growth factor (FGF-2). We hypothesize that the 3D-printed gelatin-silk fibroin composite scaffold incorporated 
with FGF-2 can promote the formation of granulation tissue, which could thus further enhance the repair of 
full-thickness skin defects.
Results
Scaffold characterization. To stabilize the incorporated FGF-2 within the composite scaffold, diazonium 
coupling chemistry was used to attach sulfonic acid moieties to tyrosine residues in the native SF. Unmodified and 
sulfonated SF derivatives were evaluated by FTIR spectra. The peaks around 1658 cm−1 (amide I) and 1540 cm−1 
(amide II) which are characteristic absorption bands for peptides and proteins, were shifted to 1625 cm−1 and 
1520 cm−1, respectively, when treated with the diazonium coupling mixture. These findings indicate the transi-
tion from a random coil to a b-sheet structure, which are similar to the results observed in previous studies28, 30, 31. 
Hence, the sulfonated SF derivatives with different modification ratios can enhance b-sheet structure formation 
by exposure to methanol. Additionally, we detected a non-specific absorption band around 1380 cm−1 in the sul-
fonated groups, as a further proof to verify that the sulfonation process has occurred. (Fig. 1A). We then assessed 
the hydrophilicity of native SF and sulfonated SF derivatives by performing advancing contact angle measure-
ment prior to chemical treatment (Fig. 1B). Films of native SF displayed contact angles of approximately 86°, 
whereas the contact angles of sulfonated SF films were gradually reduced with increasing levels of sulfonation. 
Both native SF and sulfonated SF derivatives could adhere onto the grid tightly. Scanning electron microscopy 
(SEM) showed that both the 3D printed gelatin grid coated by pure SF (3DG-SF, pore size = 100~200 μm) and 
the 3D printed gelatin grid coated by sulfonated SF (3DG-SF-SO3, pore size = 400~500 μm.) displayed porous 
structures (Fig. 1C). Higher magnification images showed that the former retained a relatively smooth surface, 
while the latter became rough and exhibited more porosity. Additionally, it was also observed that the sulfonated 
SF derivative scaffold formed a highly interconnected structure. The porosity of 3DG, 3DG-SF, 3DG-SF-SO3 were 
~82.1%, ~88.0%, and ~87.6%, respectively. (SFig. 1).
Effects of FGF-2 on cellular behavior. FGF-2 was cloned from the cDNA of A549 cells (human lung ade-
nocarcinoma cell line) and was subsequently expressed in Escherichia coli BL21 through the plasmid pGEX-6P-1 
GST Expression Vector according to previous studies32, 33. Highly purified FGF-2 with a single band at ~17 kDa 
was obtained after protein purification (Fig. 2A). The biological effects of FGF-2 at different concentrations were 
evaluated on child foreskin fibroblasts (CFFs), including cell proliferation and migration. CCK-8 assays showed 
that cells exhibited similar proliferation rates with or without FGF-2 on both day 1 and day 3; however, on day 5, 
the enhancement of proliferation rate was observed to be the most significantly increased (approximately 40%) 
when treated with FGF-2 at 100 ng/ml concentration (Fig. 2B).
Effects of the released FGF-2 at different concentrations from the 3DG-SF-SO3-FGF scaffold on CFF prolif-
eration were also evaluated. The results illustrated a similar pattern with a rate of 75% increase in proliferation 
rate at 100 ng/ml FGF-2, which is the optimal concentration (Fig. 2C). Hence, we utilized 100 ng/ml FGF-2 for 
further studies. Moreover, results of the wound healing assay demonstrated a significant enhancement of CFF 
migration with an addition of FGF-2 (100 ng/ml) (Fig. 2D,E). The in vitro release profile of FGF-2 from the 
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Figure 1. Characterization of scaffolds. (A) Comparison of the ATR-FTIR spectra of unmodified and 
sulfonated silk. (B) Advancing contact angles of native SF and SF derivatives with 0, 1, 2, 3 and 4 volumes per 
16 volumes of silk. (C) Micrographs of 3D printed scaffolds (3DG) (a), SF coated 3D printed scaffold (3DG-
SF) (b) and SF derivatives coated 3D printed scaffold (3DG-SF-SO3) (c). Scanning electron microscopy (SEM) 
images of 3DG scaffold (d and g), 3DG-SF scaffold (e and h), and 3DG-SF-SO3 scaffold (f and i), with (g,h,i) at 
high magnification. The thickness of each layer is 100 μm, and the whole thickness of printed gelatin and gelatin 
coated with sulfonated silk fibroin scaffold is 1 mm. Scale bars, 500 μm.
Figure 2. Effects of FGF-2 on child foreskin fibroblasts (CFFs). Purification of FGF-2 (A), and effects of free 
FGF-2 (B) and FGF-2 released from scaffold (C) on CFFs proliferation during 5-day culture time. Effects of free 
FGF-2 (100 ng/ml) on cell migration at 0 h, 12 h and 24 h, n = 3; Scale bars, 500 μm. (D–E) and FGF-2 (initial 
concentration:100 ng/ml) is continuously released from the scaffold over time, n = 3. (F).
www.nature.com/scientificreports/
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3DG-SF-SO3-FGF scaffold was demonstrated in Fig. 2F. A burst release of 32% was detected during the first initial 
24 hours, followed by a constant slow-release profile. By day 12, 30% of the incorporated FGF-2 still remained 
within the scaffold. These data collectively suggest that both free and scaffold-adsorbed FGF-2 possess bioactivity, 
and that the latter format exhibited a sustained release profile.
Morphology and proliferation of CFF on 3D printed scaffolds. To assess the effects of the sulfonated 
SF derivative on cell adhesion and growth, we seeded CFFs on native SF scaffolds, sulfonated SF scaffolds and 
FGF-2 modified sulfonated SF scaffolds, and observed cell morphologies by SEM on day 1 and day 3 (Fig. 3). 
SEM micrographs indicated that CFFs can adhere to the native SF scaffold (Fig. 3a and d), sulfonated SF scaffold 
(Fig. 3b and e) and FGF-2 incorporated sulfonated SF scaffold (Fig. 3c and f). After 3 days in culture, the number 
of adherent cells was visualized to be higher on the FGF-2 incorporated sulfonated SF scaffolds, as compared to 
the native and sulfonated SF scaffold (Fig. 3f). Additionally, cells cultured on sulfonated SF scaffolds exhibited 
more spreading, covering greater cell attachment surface areas (Fig. 3e and f). Hence, these results conclusively 
demonstrated that sulfonated SF coated scaffolds support cell adhesion, spreading, and growth.
Effects of 3D printed FGF-2 incorporated scaffolds on skin repair and blood vessel forma-
tion. In order to evaluate the effects of 3D printed scaffolds on skin repair, both 3DG-SF-SO3-FGF scaffolds and 
3DG-SF-SO3 scaffolds were transplanted onto a full-thickness skin defect on the rat dorsal surface (Fig. 4A)34, 35. 
In order to observe wound healing and vascularization, newly formed tissues from the dorsal skin of the rat 
back were retrieved and visualized quickly after 14 and 28 days postoperatively. The results showed that the 
3DG-SF-SO3-FGF scaffold helped smoothen the wounds after surgery, and more blood vessels were visible in the 
3DG-SF-SO3-FGF group as shown in Fig. 4B(c and f).
Histological staining was also employed to evaluate wound healing on samples harvested on day 14 and day 
28 post-implantation (Figs 5 and 6). As shown in Fig. 5, the three columns represent the left, middle and right 
regions of the wound. The yellow line indicates the boundary between the wound and the surrounding normal 
skin. In all three groups, fibroblasts migrated from the wound bed, and granulation was initiated as the defect site 
was replaced with regenerating tissues (Fig. 5A,B). Compared with the petroleum gauze group (Fig. 5a,b and c), 
where sparse and bare epithelial layers were formed at the wound site, epithelial cells displayed a tendency to 
migrate from the edge of normal skin towards the center of the wound in the 3DG-SF-SO3 group (Fig. 5e,f and g). 
In contrast, almost completely repaired dermis and epidermis layers were displayed in the 3DG-SF-SO3-FGF 
group on day 14 post-implantation (Fig.  5i,j and k). These differences were further confirmed by 
Figure 3. Morphology of CFFs cultured on pure SF scaffolds (a and d), sulfated SF (SF-SO3) scaffolds 
(b and e) and FGF-2 incorporated sulfonated SF (SF-SO3-FGF) scaffolds (c and f) at day 1 and day 3. 
Magnification = 400X. n = 3; Scale bars, 100 μm.
www.nature.com/scientificreports/
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visualizing magnified images of the middle region of the wound (Fig. 5d,h and l). Additionally, within the mag-
nified images, small vessels and fresh red blood cells can be detected in the dermal layer of the 3DG-SF-SO3 and 
3DG-SF-SO3-FGF groups (Fig. 5h and l). The revascularization was observed to be more widely distributed in the 
FGF-2 incorporated scaffold group, as compared to the scaffold alone group. By contrast, revascularization can 
hardly be observed in the control group (Fig. 5d).
By day 28 post-surgery, the defect sites were observed to be completely closed by re-epithelization in both the 
3D printed scaffold groups (3DG-SF-SO3 and 3DG-SF-SO3-FGF), while the epidermis layer was still not com-
pletely formed at the center of the wound in the control group (Fig. 6a–c,e–g,i–k). As shown in Fig. 6d,h and l, 
blood vessels were presented sporadically when treated with petroleum gauze. Upon comparing blood vessel 
formation, it was observed that the number of blood vessels presented on day 28 decreased dramatically when 
compared to day 14, and exhibited a more normal blood vessel morphology. (Fig. 6d,h,l).
Masson trichrome staining showed that the collagen content increased over time after implantation. On day 
14 post-surgery, the histological appearance of skin defects implanted with the 3DG-SF-SO3-FGF scaffolds dis-
played organized collagen fibers with corrugated structure (Fig. 7c), whereas collagen fibers in the 3DG-SF-SO3 
scaffolds (Fig. 7b) and control groups (Fig. 7a) were highly disordered. By day 28 post-surgery, collagen was more 
highly expressed in the 3DG-SF-SO3-FGF (Fig. 7f) and 3DG-SF-SO3 (Fig. 7e) groups, as compared to the control 
group (Fig. 7d).
Blood Vessel and Epidermis Formation in Skin Defects. For further characterization of blood vessel 
and epidermis formation in the skin defects, immunohistochemistry was performed to analyze expression levels 
of α-SMA and CD31 on day 28 post-surgery. As shown in the upper panel of Fig. 8, in contrast to the control 
group, pan-cytokeratin expression showed complete re-epithelialization in both 3D printed scaffolds. However, 
the staining results showed a significantly thicker epithelial layer in the 3DG-SF-SO3-FGF group when compared 
to scaffolds lacking FGF-2. Similarly, immunostaining for blood vessel related proteins α-SMA and CD31 showed 
that these were up-regulated upon the release of FGF-2 from the 3DG-SF-SO3-FGF scaffold, as compared to the 
control group.
Discussion
In this study, we demonstrated that 3D printed gelatin-based silk fibroin (SF) scaffolds promoted healing 
of full-thickness skin defects, and that incorporation of FGF-2 could further enhance the treatment efficacy. 
Modified SF with sulfonated moieties was utilized in the scaffold to increase its hydrophilicity, as well as facilitate 
incorporation of FGF-2. It was demonstrated that the immobilized growth factor FGF-2 exhibited sustained 
release kinetics and was able to stimulate cell proliferation and migration in vitro. Subsequently, the 3D printed 
scaffold exhibited promising results when utilized to treat full-thickness cutaneous injuries in an animal model. 
As demonstrated in the results, incorporation of FGF-2 within the scaffold enhanced proliferation rate (from 
~40% to ~75%), tissue morphology, collagen fibril assembly, blood vessel formation, and expression of various 
corresponding markers. These data thus suggest that recombinant FGF-2 delivered by the 3D printed scaffold 
could be a viable and innovative therapeutic strategy for severe skin defects.
Increasing evidence from previous studies suggest that silk composite scaffolds display positive efficacy in 
full-thickness skin regeneration and wound healing upon incorporation with specific growth factors and cells36–38. 
Although proven to be beneficial, the relatively slow degradation rate of silk composite scaffolds is incompatible 
with regenerating tissues, thus reducing its efficacy. In this study, we evaluated the degradation rate of pure silk 
fibroin in two different solutions: 0.1 M PBS buffer and 1 mg/ml alpha-chymotrypsin solution, and no significant 
degradation was observed in both solutions (SFig. 2). In contrast, the tensile strength were decreased to ~60% 
when SF scaffolds were immersed in alpha-chymotrypsin solution after 42 days (SFig. 3). Therefore, blending SF 
with other materials like gelatin is utilized in order to accelerate the degradation rate.
Figure 4. 3DG-SF-SO3-FGF scaffolds were applied to full-thickness skin wounds and compared to wounds 
treated with petroleum gauze (control) or 3DG-SF-SO3 scaffolds. (A) Micrographs of animal surgery (a,b). (B) 
Gross observation of angiogenesis within newly formed tissues of healing wounds at day 14 and day 28 post-
surgery. Scale bars, 50 μm.
www.nature.com/scientificreports/
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Figure 5. Representative H&E staining of skin tissue sections at 14 days post-surgery. which illustrate the 
healing process at the left (a,e,i), centre (b,f,j) and right regions of the wound (c,g,k). Yellow lines in the images 
indicated the boundaries between the wound and the surrounding normal skin. (B) Magnified view (d,h,l) of 
the regions in green pane in figure (A) (b,f and j). Scale bars = 200 μm (A), and 100 μm (B) respectively.
Figure 6. Representative H&E staining of skin tissue sections at day 28 post-surgery. Which illustrate the 
healing process at the left (a,e,i), centre (b,f,j), and right of the wound (c,g,k). Yellow lines in the images 
indicated the boundaries between the wound and the surrounding normal skin. (B) Magnified view (d,h,l) of 
the regions in green pane in figure (A) (b, f and j). Scale bars = 200 μm (A), and 100 μm (B) respectively.
www.nature.com/scientificreports/
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As a collagen derivative, gelatin possesses good biocompatibility and exhibits fast degradation rate, which is 
advantageous for tissue engineering applications. Currently, there are increasing numbers of studies on the use 
of gelatin and silk fibroin interpenetrating polymer composite scaffolds fabricated by various means (chemical 
cross-linking or simple blending) for diverse tissue engineering applications, with the scaffold functioning as 
either a structural component of tissue engineering or to facilitate drug delivery39–41. Previous studies have shown 
that gelatin-incorporated scaffolds were able to stimulate fibroblasts adhesion and proliferation. However, only a 
few studies have investigated this type of composite biopolymer scaffold for skin wound healing42–44.
Figure 7. Masson trichrome staining shows histology of repaired wound after treatment. with petroleum gauze 
(a,d), 3DG-SF-SO3 scaffold (b,e) and 3DG-SF-SO3-FGF scaffold (c,f) at 14 and 28 days post-surgery. Scale 
bars = 100 μm.
Figure 8. Epidermis and blood vessel formation in skin defects. Immunohistochemical staining of wound 
sections to detect expression of cytokeratin, SMA and CD31, after implantation with 3DG-SF-SO3 and 3DG-SF-
SO3-FGF scaffolds at day 28 post-surgery. Scale bars = 50 μm.
www.nature.com/scientificreports/
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In this study, a novel strategy was employed in which the basic structural framework was composed of 
fast-degrading gelatin, with its surface and the mesh being covered or filled with silk fibroin. By combining with 
SF and sulfonated SF, the pure gelatin scaffold was provided with enhanced mechanical support (SFig. 4). After 
confirming the relatively low cytotoxicity of the composite in vitro (SFig. 5), we further investigated its advantages 
of in vivo applications. A complex cascade of highly orchestrated and overlapping processes of clotting (hemo-
stasis), re-epithelialization (migration and proliferation), and remodeling (maturation) naturally takes place after 
skin injuries. Wound granulation is an important stage in skin healing, and represents a critical part of the migra-
tion and proliferation phase45. Upon gelatin degradation, the SF mesh provides a microscale porous structure that 
subsequently facilitates wound granulation by guiding columnar tissue to grow through the mesh and fills up the 
wound in order to restore function46.
Generally, epithelialization can only take place after the granulated tissue reaches the level of the sur-
rounding skin, while epithelial cells migrate across the new tissue to form a barrier between the wound and 
the environment47. However, as shown in Fig. 5 of our study, although granulation was observed in all three 
groups, no epithelialization occurred in the control group. In a recently proposed novel theoretical model, the 
re-epithelialization phase is driven by chemotaxis for a circular wound, and can be utilized to explain the obser-
vations in this study48. As a matter of fact, re-epithelialization is dependent on the synergistic effects of multiple 
factors, including physical microenvironment and growth factors.
Angiogenesis and neovascularization are crucial for skin wound healing, as newly formed blood vessels pro-
vide nutrition and oxygen to growing tissues7. FGF-2 is a multifunctional poly-peptide that promotes growth, 
migration and differentiation of a broad variety of cell types, including dermal fibroblasts, keratinocytes, endothe-
lial cells and melanocytes49, which was demonstrated by the in vitro cell growth and scratch experiments. FGF-2 
was also proved to stimulate VEGF expression, granulation tissue formation, and blood vessel maturation50, 51. 
In the in vivo skin wound repair model utilized in this study, immunohistochemistry displayed significantly 
increased expression of blood vessel related proteins such as α-SMA and CD31. Analysis of the FGF-2 release 
kinetics showed a continuous released of FGF-2 from the sulfonated silk scaffold, due to its binding with the sul-
fonated silk fibroin that mimicking the natural interactions between FGF-2 and the sulfated glycosaminoglycan 
heparan sulfate in the ECM. Thus, continuous release of FGF-2 from the scaffold contributed to the increased 
expression of blood vessel related proteins in the rat model. These data demonstrated the biological role of FGF-2 
in recruiting endogenous cell for epithelialization and blood vessel formation at the defect site.
At present, techniques to incorporate growth factors within biomaterials mainly focuses on two strategies, 
direct mixing52 and chemical covalent linkage53. The major shortcomings of direct mixing are low loading effi-
ciency and inadequate growth factor release. On the other hand, covalent linkage is associated with harsh chem-
ical treatment that compromises the bioactivity of growth factors. In nature, association of growth factors and 
ECM in tissues involves non-covalent interactions i.e. electrostatic interactions. Modification of SF with sulfonic 
acid moieties could mimic the natural ECM and confer high capacity for sequestration, as well as enable sustained 
slow-release of FGF-231. Hence, we utilized this non-covalent interaction between SF derivatives and FGF-2 to 
achieve a slow release system. Furthermore, addition of sulfonated moieties to SF can gradually increase the 
hydrophilicity of SF, which could result in enhanced cell adhesion and increased bioactivity on a more hydro-
philic biomaterial surface. This may be the reason for the observed enhancement of cell adhesion in our study. 
The mechanical properties of silk depend mainly on its natural structure54. Although addition of chemical moie-
ties to SF may alter the pore size, damage to the natural structure of silk fibroin was not observed (Fig. 1b and c).
Currently, cultured Epidermal Autograft (CEA) and Split Thickness Skin Graft (STSG) are the most wide-
spread treatment modalities for severe burns in the clinic55. However, these grafts are not satisfactory and effective 
in repairing large area skin damage56 and chronic skin wounds due to lower granulation57, and lack of vascular-
ization during the process of wound healing35. Our silk fibroin derivative has demonstrated great potential for 
such types of major cutaneous defects, and further investigations in big animal models will be performed in the 
near future.
Materials and Methods
Materials and chemical processing. Bombyx mori silk fibroin solution (6% w/v) was purchased from 
Zhejiang Cathaya International Inc. (Hangzhou, China). The diazonium coupling reaction was carried out as 
previously described31. Briefly, 4 mL of 4-sulfanilic acid (0.2 M) and 2 mL of aqueous solution of p-toluenesulfonic 
acid (1.6 M) were combined and quickly vortexed. Then, 2 mL of aqueous solution of NaNO2 (0.8 M) was added to 
the mixture before placing it on ice for 30 min. Subsequently, the SF solution was then reacted with the prepared 
salt solution in borate buffer. To control the level of sulfonation, different volumes of the diazonium salt (0, 1, 2, 3, 
or 4 volume) were added dropwise to the SF solution (16 volumes) in order to achieve the optimum composition. 
Sulfonated silk fibroin derivatives were purified by dialysis with distilled water for three days.
Preparation of 3DG-SF-SO3-FGF scaffolds. Fabrication of the 3DG-SF-SO3 scaffold was comprised of 
three steps. Initially, gelatin powder was sterilized by UV-radiation and dissolved in distilled water at a concen-
tration of 2% (w/v). A 2 cm * 2 cm gelatin grid (the basic network of the scaffold) was produced by a self-made 
pneumatic bio-printing system58 with a syringe nozzle of 100 μm and printing velocity of 5 mm/s within a laminar 
flow-cabinet. After printing, the scaffolds were cross-linked with 1% (m/v) EDC-NHS solution for 2 hrs. Then, 
the sulfonated silk fibroin derivative was poured onto the 3D printed scaffolds, followed by temporary storage at 
4 °C for 4 hours and subsequent freezing (−80 °C) for 12 hrs. Finally, the scaffold was soaked in FGF-2 solution 
(100 μg/ml) overnight to absorb the growth factor, followed by storage after sterilization through gamma irradi-
ation. The intensity used for sterilization is 20~25 KGy. Since the thickness of the epidermis and dermis layer is 
theoretically thought to be between 1–10 mm depending on the specific part of the body, we chose to print the 
gelatin scaffolds mimicking the skin thickness within the normal range.
www.nature.com/scientificreports/
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Scaffolds characterization. Films of native SF and sulfonated SF derivatives were characterized directly 
by Fourier transform infrared spectroscopy (Nicolet, AVA TAR370) as previously described. Aqueous solutions 
(6%) of native SF and sulfonated SF derivatives were spread on glass slides and dried overnight. Films were then 
exposed to water vapor of 96% relative humidity by equilibration in the presence of a saturated aqueous Na2SO4 
solution at room temperature for 12 h, as previously described59, 60, followed by drying. This treatment is denoted 
as water vapor treatment. Advancing water-contact angles were analyzed using a drop shape analyzer. The poros-
ities of 3D gelatin scaffold and 3D gelatin scaffold with native or sulfonated SF were tested by AutoPore IV 9500 
V1.07 (Micromeritics Instrument Corporation).
Mechanical evaluation. The mechanical stretch properties of the 3D gelatin scaffold and 3D gelatin scaffold 
with native or sulfonated SF were tested by using the Instron testing machine (model 5543; Instron, Canton, MA) 
and software (Bluehill V2.0; Instron). The unconfined equilibrium modulus was also determined by applying 
a step displacement (20% strain), monitoring the stress in relations with time until equilibrium was reached. 
Physical thickness of the scaffolds was measured, and the stress-strain relations were evaluated. The crosshead 
speed used was approximately 0.06 mm/min. The ratio of equilibrium force to cross-sectional area was divided by 
the applied strain to calculate the equilibrium modulus (in MPa).
FGF-2 release from 3DG-SF-SO3-FGF scaffolds. To analyze the FGF-2 release profile from 
3DG-SF-SO3-FGF scaffolds, the whole scaffold was soaked in PBS and the medium was collected at different time 
points, with 3DG-SF-SO3 scaffolds being represented as a control group. Protein concentrations of FGF-2 within 
the medium were then determined by a kit (Micro BCA Protein Assay Kit; Thermo Scientific).
Effects of FGF-2 on cell proliferation. The child foreskin fibroblasts (CFFs) were kindly provided by 
Prof. Ji Junfeng, and CFFs were obtained from two donors, 10 aliquots from each donor. All cells were cultured 
in DMEM supplemented with 10% (v/v) fetal bovine serum at 37 °C within a humidified atmosphere of 5% CO2 
and 95% air, and the medium was replaced every 3 days. Proliferation of child foreskin fibroblasts (CFF) was 
assayed by the Cell Counting KIT-8 (CCK-8) according to the manufacturer’s instructions. Cells were cultured 
on scaffolds in growth medium containing different concentrations of FGF-2 (0, 10, 20, 50, 100 and 150 ng/ml) 
for 1, 3 and 5 days, followed by incubation in 10% (v/v) CCK-8 solution in a 5% CO2 incubator at 37 °C for 3 h. 
The absorbance of the culture medium was then measured at 450 nm. Effects of the released FGF-2 from the 
3DG-SF-SO3-FGF scaffold on CFF proliferation were also examined using the same method.
Cell migration assay. CFF (1 × 105) were seeded in 6-well culture plates to form a confluent monolayer. 
After incubation with FGF-2 for about 6 h, the cell monolayer was scraped in a straight line to create a “scratch” 
with a p200 pipet tip. The culture plate was then placed back into the incubator for 0 h, 12 h, 24 h, and digital 
images of the scratched region were captured under a phase-contrast microscopy. The rate of migration was 
determined by quantifying the average distance of the cellular movement from the edge towards the center of the 
scratch by Image Pro-Plus software61.
Observation of cell morphology. CFF were cultured on 3D printed scaffolds at a density of 1 × 104 cells/
ml. Specimens were harvested on days 1 and 3 and fixed in 2.5% (w/v) glutaraldehyde solution for 24 h. After rins-
ing three times in PBS, the specimens were immersed in OsO4 (Ted Pella) for 1 h and then rinsed 3 times again 
in PBS. Subsequently, specimens were dehydrated in increasing concentrations of acetone, then mounted on alu-
minum stubs, coated with gold, and characterized by SEM (Hitachi S-3000N, Japan) at an accelerating voltage of 
15 kV or 20 kV. For cell-free scaffolds, specimens were mounted on aluminum stubs and coated directly with gold.
Cytotoxicity evaluation of scaffolds. The cytotoxicity of scaffolds was assessed according to the 
Biological Evaluation of Medical Devices protocol (GB/T 16886.5-2003/ISO 10993-5:1999). Three groups of 
medium were prepared. The basic medium consisted of high glucose DMEM with 10% (v/v) FBS, which was 
assigned as the blank control group. The positive control group was constituted of the basic medium with 5% 
(v/v) DMSO (Sigma–Aldrich Inc., St. Louis, USA). For the experimental group, sterilized scaffolds were soaked 
in 10 ml of the basic medium for more than 48 h in 37 °C before utilization. 100 ul aliquots of L929 cell suspen-
sion (1 × 104/ml) (Chinese Academy of Sciences, Beijing, China) constituted in basic medium, were seeded 
in every single well of 96-well plates (Corning Inc., NY, USA),. Twenty-four hours later, the original medium 
was replaced with the basic medium, positive control group medium, and experimental group medium. L929 
proliferation was assessed by the CCK-8 kit with absorbance readings being measured at 450 nm after 72 h in 
culture62.
Rat skin defect model. All animal procedures complied with the Guidelines for the Care and Use of 
Laboratory Animals and were under the supervision of the Institutional Animal Care and Use Committee of 
Zhejiang University (ethics approval number: ZJU20160305). 36 male Sprague Dawley rats weighing 200–220 g 
were randomly assigned to two groups, and each group was further sub-divided into two time points (14 and 
28 days post-surgery). After general anesthesia with 10% (w/v) chloralic hydras (400 mg/kg bodyweight), a 
full-thickness defect of 20 mm * 20 mm in dimensions extending through the panniculus carnosus was gen-
erated on the back of the rats63. The defects were implanted with sulfonated SF coated scaffolds (3DG-SF-SO3), 
sulfonated SF coated scaffolds with FGF-2 (3DG-SF-SO3-FGF), or petroleum gauze (control). Gauze pads were 
used to prevent removal of grafts from the wound. Post-operatively, animals were allowed to return to their cage 
after surgery.
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Gross morphology, Histological examination and Masson trichrome staining. At 14 and 
28 days post-surgery, rats were sacrificed by an intravenous overdose of pentobarbital. Harvested spec-
imens were immediately fixed in 4% (w/v) neutral buffered formalin for 24 h, then dehydrated through 
an alcohol gradient, and embedded in paraffin blocks. Histological sections (6 μm) were prepared using a 
microtome and were subsequently stained with hematoxylin and eosin (HE). Masson trichrome staining was 
performed on the basis of standard experimental procedures to compare the gross morphology of collagen 
fibers between the experimental and control groups64. The stained sections were photographed digitally 
under a microscope.
Immunohistochemistry. To analyze epithelialization and vascularization of the regenerated tissues, 
immune-histochemical staining was performed on paraffin sections. Rat paraffin sections (6 µm in thickness) 
were incubated with 0.4% pepsin (Sangon Biotech, Shanghai, China) in 5 mM HCl at 37 °C for 20 min for antigen 
retrieval. Endogenous peroxidase was blocked by incubation with 3% (v/v) hydrogen peroxide in methanol for 
5 min. Non-specific protein binding was blocked by incubation with 2% (w/v) BSA. After overnight incubation 
at 4 °C with primary antibodies, the sections were then incubated with goat anti-mouse (Beyotime Institute of 
Biotechnology Inc., Jiangsu, China) secondary antibodies for 2 h at room temperature. The DAB substrate system 
(Zsbio, Beijing, China) was used for color development. Finally, cell nuclei were stained with Hematoxylin and 
photographed digitally.
Statistical and data analysis. All quantitative data were presented as mean ± standard deviation of at 
least 3 replicate samples from each group. Student’s t-test was performed to assess whether there were statistically 
significant differences in the results between groups. Significance levels were presented as either *p < 0.05 or 
**p < 0.01.
Ethical approval. The animal experiments were under the supervision of the Institutional Animal Care and 
Use Committee of Zhejiang University (ethics approval number: ZJU20160305).
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